Document is current
Any future updates will be listed below
-
Authors
Doustmohammadian, Azam https://orcid.org/0000-0001-6249-2520
Zamani, Farhad https://orcid.org/0000-0003-2860-9427
Hébert, James R. https://orcid.org/0000-0002-0677-2672
Moradi-Lakeh, Maziar https://orcid.org/0000-0001-7381-5305
Esfandyiari, Sepideh https://orcid.org/0009-0003-4090-0740
Amirkalali, Bahareh https://orcid.org/0000-0001-6068-4019
Motamed, Nima https://orcid.org/0000-0001-9077-0989
Maadi, Mansooreh https://orcid.org/0000-0003-1754-3864
Price, Sherry https://orcid.org/0009-0006-3547-0493
Gholizadeh, Esmaeel https://orcid.org/0000-0002-4129-4733
Ajdarkosh, Hossein https://orcid.org/0000-0002-1220-8402
-
Funding
Funding for this research was provided by:
Iran University of Medical Sciences (1401-3-75-22501)
- License Information
-
More Information
Article History
Received: 9 November 2024
Accepted: 14 December 2024
First Online: 24 December 2024
Declarations
:
: The investigation followed the guidelines specified in the Declaration of Helsinki and received approval from the ethical committee of the Iran University of Medical Sciences (IUMS) with the reference code IR.IUMS.REC.1401.950. Each individual involved in the study provided written consent after receiving comprehensive information regarding the study’s aims and procedures.
: The authors declare no competing interests.
: Not applicable.
: Dr. James R. Hébert is the primary shareholder of Connecting Health Innovations LLC (CHI), which has secured authorization for his innovation, the dietary inflammatory index (DII<sup>®</sup>), from the University of South Carolina. CHI plans to use this invention to create computer and smartphone applications for patient counseling and dietary intervention in clinical settings. CHI also holds the exclusive rights to the E-DII™. The content of this paper is not related to CHI’s work, and CHI has not influenced this project in any way.
